Skip to main content
Premium Trial:

Request an Annual Quote

Open Medicine Foundation Commits $1.8M to Research ME/CFS at Harvard Hospitals

NEW YORK (GenomeWeb) – The Open Medicine Foundation (OMF) announced today that it has committed $1.8 million to support the creation of a new myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research center at Harvard Medical School-affiliated hospitals.

The new center — which will be led by OMF scientific advisory board member Ronald Tompkins and Harvard's Wenzhong Xiao — will be tasked with generating molecular data on muscle and other tissues affected by ME/CFS using genomics, proteomics, and ultrastructural analysis, according to OMF. It will also facilitate multi-center clinical studies on potential effective treatments for the conditions.

In December, OMF put up $1.2 million to fund the first year of operations for a newly established ME/CFS collaborative research center at Stanford University. The organization has also recently provided funding to expand the Stanford Data Center for the Severely Ill Patients study to include any data from its sponsored research initiatives.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.